Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-13-004245)

Filing Details

Accession Number:: 0001140361-13-004245
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-02-01 17:16:56
Reporting Period:: 2013-01-30

Filing Date:: 2013-02-01
Accepted Time:: 2013-02-01 17:16:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1379006	Nanoviricides Inc.	NNVC.OB	Services-Commercial Physical & Biological Research (8731)	760674577

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1451613	Theracour Pharma, Inc.	135 Wood Street Suite 205 West Haven CT 06516		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-01-30	39,000	$0.50	33,321,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents restricted shares of common stock transferred by TheraCour Pharma, Inc. to a non-affiliated third party consultant for services. The party elected to be paid in restricted shares of NanoViricides, Inc. common stock.